Top compounds associated with response to RP11-894J14.5


Feature Type Standardized
Nominal ANOVA
mRNA CIL55A CTRPv2 pan-cancer AAC 0.038 0.5
mRNA Bortezomib CTRPv2 pan-cancer AAC 0.026 0.5
mRNA BRD-K20514654 CTRPv2 pan-cancer AAC 0.038 0.5
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.5
mRNA lomeguatrib CTRPv2 pan-cancer AAC -0.028 0.5
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.025 0.5
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.5
mRNA hyperforin CTRPv2 pan-cancer AAC 0.029 0.5
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.026 0.5
mRNA decitabine CTRPv2 pan-cancer AAC 0.02 0.5
Download CSV